GSK233705

CAS No. 850607-58-8

GSK233705( —— )

Catalog No. M34566 CAS No. 850607-58-8

GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 182 In Stock
10MG 274 In Stock
25MG 448 In Stock
50MG 641 In Stock
100MG 914 In Stock
200MG Get Quote In Stock
500MG 1832 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GSK233705
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans.
  • Description
    GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    850607-58-8
  • Formula Weight
    425.4
  • Molecular Formula
    C24H29BrN2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C[C@@H]1C[C@]2([N+](C)(C)[C@@](C1)(CC2)[H])[H])(C#N)(C3=CC=CC=C3)C4=CC=CC=C4.[Br-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Nitrocaramiphen hydr...

    Nitrocaramiphen hydrochloride is a selective M1 muscarinic antagonist and inhibits binding to sigma sites in brain.

  • McN-A 343

    McN-A 343 is a selective M1 muscarinic agonist known for its ability to stimulate muscarinic transmission in sympathetic ganglia.

  • 4-DAMP

    4-DAMP (4-DAMP methiodide) is a selective muscarinic M1 and M3 subtype receptor antagonist used in the study of allergic rhinitis and cardiovascular disease.